Vitamin D Supplementation Affects The Beck Depression Inventory, Insulin Resistance, And Biomarkers Of Oxidative Stress In Patients With Major Depressive Disorder: A Randomized, Controlled Clinical Trial
|Values||Serum insulin levels: (-3.6 μIU/ml for Vitamin D, compared to + 2.9 μIU/ml for placebo, P = 0.06)|
|Trial Design||Randomized trial|
|Trial Length||1-6 months|
|Number of Subjects||40|
|Age Range||18-29, 30-44, 45-64, 65+|
|Body Types||Untrained, Average|
In a randomized, double-blinded and placebo-controlled clinical trial high-dose vitamin D supplementation was shown to reduce depressive symptoms and improver markers for glucose homeostasis in individuals with major depressive disorder (MDD).